We use cookies to improve security, personalize the user experience, enhance our marketing activities (including cooperating with our marketing partners) and for other business use.
Click "here" to read our Cookie Policy. By clicking "Accept" you agree to the use of cookies. Read less
Read more
Accept
Loading
Form preview
  • US Legal Forms
  • Form Library
  • More Forms
  • More Uncategorized Forms
  • Ind Application For Botanical Drug Products - Ictr Johnshopkins

Get Ind Application For Botanical Drug Products - Ictr Johnshopkins

IND Application for Botanical Drug Products: Nonmarketed Botanical Drug Products OR Products with Known Safety Concerns ICTR Navigator July 30, 2013 Version 1.0 Page 1 of 43 ICTR DDRS: Nonmarketed.

How it works

  1. Open form

    Open form follow the instructions

  2. Easily sign form

    Easily sign the form with your finger

  3. Share form

    Send filled & signed form or save

How to fill out the IND Application For Botanical Drug Products - Ictr Johnshopkins online

This guide provides a thorough overview of how to complete the IND Application for Botanical Drug Products, focusing on nonmarketed botanical products or those with known safety concerns. Users will find step-by-step instructions tailored to ensure a smooth online submission process.

Follow the steps to efficiently fill out the application online.

  1. Click the ‘Get Form’ button to obtain the required form and open it for editing.
  2. Complete the cover letter using the sponsor-investigator's letterhead. Include the FDA address, the date, and a brief description of the botanical drug product, specifying whether it is unmarketed or has safety concerns.
  3. On the title page, insert relevant details including the date of application, the name of the botanical drug product, and sponsor-investigator information.
  4. Fill out Form FDA 1571, ensuring it is signed and dated, providing links to form instructions if necessary.
  5. Complete Form FDA 3674, also ensuring it is signed and dated.
  6. Prepare the table of contents, outlining each section of the application clearly, especially if submitting multiple volumes.
  7. Draft an introductory statement that includes the name of the botanical drug product, a brief description, and any relevant pre-IND meeting references.
  8. Develop the general investigational plan, covering rationale, indications to be studied, evaluated general approaches, and anticipated risks based on previous studies.
  9. If applicable, insert the investigator's brochure. If not, request a waiver from this requirement.
  10. Complete the protocol section by detailing the clinical protocols that will be followed.
  11. Detail the chemistry, manufacturing, and controls relevant to the botanical product, including all descriptions as specified by the FDA guidelines.
  12. Compile any pharmacology and toxicology data necessary for the safety assessment of the proposed studies.
  13. Summarize previous human experience related to the investigational drug, outlining any relevant studies and findings.
  14. Include additional information as required by the application specifications, addressing any known drug dependence or abuse potential.
  15. Review the submitted documents for completeness, save changes, download or print the application, and ensure all forms are correctly filled out and attached.

To begin your application process, click the ‘Get Form’ button and start filling out your IND Application for Botanical Drug Products online.

Get form

Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.
Get form

Related content

Proceedings of the Indo-US bilateral workshop on...
Feb 3, 2013 — Keywords: Biologics, botanicals, cancer, chemoprevention, drug development...
Learn more
Investigational Botanical Drug Products | ICTR
To request this template, please email our research navigators at...
Learn more
Chemical Engineering,Chemistry,BioChemistry 643...
$113 ISBN: 0080439381 Pages: 3D QSAR in Drug Design, Volume 2. ... Agricultural...
Learn more

Related links form

1 8 Practice Form K Answers CHILD AND ADULT FOOD PROGRAM MONTHLY MEAL COUNT ... - Nj Fort Hood Form 550 886-4591 (8-16) GENERAL CONSENT TO TERMINATION OF PARENTAL RIGHTS AND ADOPTION - Dss Mo

Questions & Answers

Get answers to your most pressing questions about US Legal Forms API.

Contact support

An IND application may go into effect: 30 days after FDA receives the application, unless FDA notifies the sponsor that the investigations described in the application are subject to a Clinical Hold; or. on earlier notification by FDA that the clinical investigations in the IND may begin.

Once the IND is submitted, the sponsor must wait 30 calendar days before initiating any clinical trials. During this time, FDA has an opportunity to review the IND for safety to assure that research subjects will not be subjected to unreasonable risk.

An IND application may go into effect: 30 days after FDA receives the application, unless FDA notifies the sponsor that the investigations described in the application are subject to a Clinical Hold; or. on earlier notification by FDA that the clinical investigations in the IND may begin.

The IND application must contain information in three broad areas: Animal Pharmacology and Toxicology Studies - Preclinical data to permit an assessment as to whether the product is reasonably safe for initial testing in humans. Also included are any previous experience with the drug in humans (often foreign use).

Phase 1: safety, proof of concept, and exploratory. Phase 2: safety, efficacy, and dose ranging. Phase 3: efficacy confirmatory, dose ranging, and safety. The IND needs to be submitted in electronically and in eCTD format.

Filing an IND requires completion of 3 sets of forms: 1 detailing the study (FDA Form 1571), 1 providing information about the investigator and study site (FDA Form 1572), and 1 certifying that the study is registered in the national database of clinical trials (FDA Form 3674).

A sponsor who would like to obtain FDA advice on study design can submit an IND for FDA review. FDA regulations describe criteria under which bioavailability or bioequivalence (BA/BE) studies using unapproved versions of approved drug products can be conducted without submission of an IND (21 CFR 320.31(b) and (d)).

The pre-IND meeting will be scheduled to occur within 60 days of receipt of the meeting request. OTAT schedules Pre-IND meetings for 60 minutes. Pre-IND meetings are Type B meetings, and follow the timelines FDA had established for Type B meetings.

Get This Form Now!

Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.
Get form
If you believe that this page should be taken down, please follow our DMCA take down processhere.

Industry-leading security and compliance

US Legal Forms protects your data by complying with industry-specific security standards.
  • In businnes since 1997
    25+ years providing professional legal documents.
  • Accredited business
    Guarantees that a business meets BBB accreditation standards in the US and Canada.
  • Secured by Braintree
    Validated Level 1 PCI DSS compliant payment gateway that accepts most major credit and debit card brands from across the globe.
Get IND Application For Botanical Drug Products - Ictr Johnshopkins
Get form
Form Packages
Adoption
Bankruptcy
Contractors
Divorce
Home Sales
Employment
Identity Theft
Incorporation
Landlord Tenant
Living Trust
Name Change
Personal Planning
Small Business
Wills & Estates
Packages A-Z
Form Categories
Affidavits
Bankruptcy
Bill of Sale
Corporate - LLC
Divorce
Employment
Identity Theft
Internet Technology
Landlord Tenant
Living Wills
Name Change
Power of Attorney
Real Estate
Small Estates
Wills
All Forms
Forms A-Z
Form Library
Customer Service
Terms of Service
Privacy Notice
Legal Hub
Content Takedown Policy
Bug Bounty Program
About Us
Blog
Affiliates
Contact Us
Delete My Account
Site Map
Industries
Forms in Spanish
Localized Forms
State-specific Forms
Forms Kit
Legal Guides
Real Estate Handbook
All Guides
Prepared for You
Notarize
Incorporation services
Our Customers
For Consumers
For Small Business
For Attorneys
Our Sites
US Legal Forms
USLegal
FormsPass
pdfFiller
signNow
airSlate WorkFlow
DocHub
Instapage
Social Media
Call us now toll free:
+1 833 426 79 33
As seen in:
  • USA Today logo picture
  • CBC News logo picture
  • LA Times logo picture
  • The Washington Post logo picture
  • AP logo picture
  • Forbes logo picture
© Copyright 1997-2025
airSlate Legal Forms, Inc.
3720 Flowood Dr, Flowood, Mississippi 39232
Form Packages
Adoption
Bankruptcy
Contractors
Divorce
Home Sales
Employment
Identity Theft
Incorporation
Landlord Tenant
Living Trust
Name Change
Personal Planning
Small Business
Wills & Estates
Packages A-Z
Form Categories
Affidavits
Bankruptcy
Bill of Sale
Corporate - LLC
Divorce
Employment
Identity Theft
Internet Technology
Landlord Tenant
Living Wills
Name Change
Power of Attorney
Real Estate
Small Estates
Wills
All Forms
Forms A-Z
Form Library
Customer Service
Terms of Service
Privacy Notice
Legal Hub
Content Takedown Policy
Bug Bounty Program
About Us
Blog
Affiliates
Contact Us
Delete My Account
Site Map
Industries
Forms in Spanish
Localized Forms
State-specific Forms
Forms Kit
Legal Guides
Real Estate Handbook
All Guides
Prepared for You
Notarize
Incorporation services
Our Customers
For Consumers
For Small Business
For Attorneys
Our Sites
US Legal Forms
USLegal
FormsPass
pdfFiller
signNow
airSlate WorkFlow
DocHub
Instapage
Social Media
Call us now toll free:
+1 833 426 79 33
As seen in:
  • USA Today logo picture
  • CBC News logo picture
  • LA Times logo picture
  • The Washington Post logo picture
  • AP logo picture
  • Forbes logo picture
© Copyright 1997-2025
airSlate Legal Forms, Inc.
3720 Flowood Dr, Flowood, Mississippi 39232